#pirola — Public Fediverse posts on home.social

With the latest Nextclade update, the first 7 FLiRT sub-lineages are now being classified. I'm now separating them from all other BA.2.86.* (including JN.1.*) lineages in a new "Lineage L2" group: JN.1.* +FLiRT.

Report link:
https://mike-honey.github.io/covid-19-genomes/output/Coronavirus%20-%20Genomic%20Sequencing%20-%20report%20UK.pdf

#COVID19 #UK #BA_2_86 #JN_1 #Pirola #KP_2

#covid19 #uk #ba_2_86 #jn_1 #pirola #kp_2

Mike Honey @[email protected] · 2024-04-16 · 13:44 UTC

CW: SARS-CoV-2 variants for Canada

Here's the latest variant picture for Canada.

BA.2.86.* "Pirola" is waning under a challenge from the JN.1.* +FLiRT sub-lineages - led by KS.1.

KP.3 is another growing sub-lineage in Canada, featuring the Spike Q493E mutation (but not R346T).

With the latest Nextclade update, the first 7 FLiRT sub-lineages are now being classified. I'm now separating them from all other BA.2.86.* (including JN.1.*) lineages in a new "Lineage L2" group: JN.1.* +FLiRT.

Report link:
https://mike-honey.github.io/covid-19-genomes/output/Coronavirus%20-%20Genomic%20Sequencing%20-%20report%20Canada.pdf

#COVID19 #Canada #BA_2_86 #JN_1 #Pirola #KP_3 #KS_1

#covid19 #canada #ba_2_86 #jn_1 #pirola #kp_3

Mike Honey @[email protected] · 2024-04-16 · 13:43 UTC

CW: SARS-CoV-2 variants for the United States

Here's the latest variant picture for the United States.

BA.2.86.* "Pirola" is waning under a challenge from the JN.1.* +FLiRT sub-lineages - led by KP.2.

With the latest Nextclade update, the first 7 FLiRT sub-lineages are now being classified. I'm now separating them from all other BA.2.86.* (including JN.1.*) lineages in a new "Lineage L2" group: JN.1.* +FLiRT.

Report link:
https://mike-honey.github.io/covid-19-genomes/output/Coronavirus%20-%20Genomic%20Sequencing%20-%20report%20USA.pdf

#COVID19 #USA #BA_2_86 #JN_1 #Pirola #KP_2

#covid19 #usa #ba_2_86 #jn_1 #pirola #kp_2

Mike Honey @[email protected] · 2024-03-05 · 10:03 UTC

CW: SARS-CoV-2 variants for New Zealand

Here's the latest variant picture for New Zealand.

As of mid-February, BA.2.86.* "Pirola" (81%) was dominant - led by the JN.1 sub-variant.

XDK (8%) has continued to grow steadily, seemingly confirming it as a viable challenger.

#COVID19 #NZ #BA_2_86 #Pirola #XDK
🧵

#covid19 #nz #ba_2_86 #pirola #xdk

Mike Honey @[email protected] · 2024-02-18 · 02:43 UTC

CW: SARS-CoV-2 variants for the UK

Here's the latest variant picture for the UK - a global bellwether for new variants with it's low protections/mitigations.

As of late January, BA.2.86.* "Pirola" (94%) was dominant - with JN.1 the leading sub-lineage (59%).

JN.1.4 (14%) is showing some growth. JN.1.4 adds the ORF1a T170I mutation to JN.1. It seems that gives it a slight advantage, but hopefully not enough to cause widespread reinfections.

#COVID19 #UK #BA_2_86 #Pirola #XDD #XDK
🧵

#covid19 #uk #ba_2_86 #pirola #xdd #xdk

Mike Honey @[email protected] · 2024-02-02 · 23:50 UTC

CW: SARS-CoV-2 variants for New Zealand

Here's the latest variant picture for New Zealand.

As of late January, BA.2.86.* "Pirola" (81%) was dominant - led by the JN.1 sub-variant.

EG.5.* "Eris" (13%) continued to decline.

XDK (3%) is growing.

#COVID19 #NZ #BA_2_86 #Pirola #EG_5 #Eris #XDK
🧵

#covid19 #nz #ba_2_86 #pirola #eg_5 #eris

Mike Honey @[email protected] · 2024-02-01 · 07:13 UTC

CW: SARS-CoV-2 variants for Japan

Here's the latest variant picture for Japan.

As of mid-January, BA.2.86.* "Pirola" (48%) was only growing slowly.

EG.5.* "Eris" (44%) was putting up much stiffer resistance than in other countries, led by a recent surge in the HK.3 sub-lineage - mainly in Tokyo.

#COVID19 #Japan #BA_2_86 #Pirola #EG_5 #Eris #HK_3
🧵

#covid19 #japan #ba_2_86 #pirola #eg_5 #eris

Mike Honey @[email protected] · 2024-02-01 · 06:23 UTC

CW: SARS-CoV-2 variants for Australia

Here's the latest variant picture for Australia.

As of late January, BA.2.86.* "Pirola" (88%) was dominant - led by the JN.1 sub-variant.

EG.5.* "Eris" (10%) continued to decline.

#COVID19 #Australia #BA_2_86 #Pirola #EG_5 #Eris @auscovid19
🧵

#covid19 #australia #ba_2_86 #pirola #eg_5 #eris

Mike Honey @[email protected] · 2024-01-25 · 10:03 UTC

CW: SARS-CoV-2 variants for Australia

Here's the latest variant picture for Australia.

As of mid-January, BA.2.86.* "Pirola" (80%) was dominant - led by the JN.1 sub-variant.

EG.5.* "Eris" (16%) continued to decline.

#COVID19 #Australia #BA_2_86 #Pirola #EG_5 #Eris @auscovid19
🧵

#covid19 #australia #ba_2_86 #pirola #eg_5 #eris

Mike Honey @[email protected] · 2024-01-11 · 21:58 UTC

CW: SARS-CoV-2 variants for Australia

Here's the latest variant picture for Australia.

As of early January, BA.2.86.* "Pirola" (73%) was dominant - led by the JN.1 sub-variant.

EG.5.* "Eris" (27%) continued to decline.

#COVID19 #Australia #BA_2_86 #Pirola #EG_5 #Eris @auscovid19
🧵

#covid19 #australia #ba_2_86 #pirola #eg_5 #eris

Mike Honey @[email protected] · 2024-01-08 · 10:18 UTC

CW: SARS-CoV-2 variants for Finland

Here's the latest variant picture for Finland.

As of late December, BA.2.86.* "Pirola" (46%) had just become dominant - led by the JN.1 sub-variant.

EG.5.* "Eris" (42%) was in a steady decline.

The growth of BA.2.86.* accelerated from early December onwards, in a now-familiar pattern.

#COVID19 #Finland #BA_2_86 #Pirola #EG_5 #Eris
🧵

#covid19 #finland #ba_2_86 #pirola #eg_5 #eris

Mike Honey @[email protected] · 2024-01-04 · 13:33 UTC

CW: SARS-CoV-2 variants for Denmark

Here's the latest variant picture for Denmark.

As of mid-December, BA.2.86.* "Pirola" (94%) was utterly dominant - led by the JN.1 sub-variant.

EG.5.* "Eris" (5%) was in sharp decline.

The growth of BA.2.86.* in Denmark appears more advanced than in other countries, so perhaps this is a roadmap to the near future elsewhere - "Pirola: Endgame".

#COVID19 #Denmark #BA_2_86 #Pirola #EG_5 #Eris
🧵

#covid19 #denmark #ba_2_86 #pirola #eg_5 #eris

Mike Honey @[email protected] · 2024-01-04 · 02:52 UTC

CW: SARS-CoV-2 variants for Australia

Here's the latest variant picture for Australia.

As of late December, BA.2.86.* "Pirola" (62%) was dominant - led by the JN.1 sub-variant.

EG.5.* "Eris" (30%) was in sharp decline.

The growth of BA.2.86.* accelerated from late November onwards, in a now-familiar pattern.

#COVID19 #Australia #BA_2_86 #Pirola #EG_5 #Eris @auscovid19
🧵

#covid19 #australia #ba_2_86 #pirola #eg_5 #eris

Mike Honey @[email protected] · 2023-12-29 · 04:09 UTC

CW: SARS-CoV-2 variants for South Australia

Here's the latest variant picture for South Australia.

As of mid-December, BA.2.86.* "Pirola" (46%) (led by the JN.1 sub-lineage) seemed dominant, rapidly displacing EG.5.* "Eris" (31%) from late November onwards.

#COVID19 #Australia #SA #Adelaide @auscovid19 #EG_5 #Eris #BA_2_86 #Pirola
🧵

#covid19 #australia #sa #adelaide #eg_5 #eris

Mike Honey @[email protected] · 2023-12-25 · 23:53 UTC

CW: SARS-CoV-2 variants for Tasmania, Australia

Here's the latest variant picture for Tasmania, Australia.

As of mid-December, EG.5.* "Eris" (47%) was generally declining.

BA.2.86.* "Pirola" (50%) began rising steadily from mid-November onwards, led by the JN.1 sub-variant.

#COVID19 #Australia #TAS @auscovid19 #EG_5 #Eris #BA_2_86 #Pirola
🧵

#covid19 #australia #tas #eg_5 #eris #ba_2_86

Mike Honey @[email protected] · 2023-12-25 · 23:41 UTC

CW: SARS-CoV-2 variants for Victoria, Australia

Here's the latest variant picture for Victoria, Australia.

As of mid-December, EG.5.* "Eris" (57%) was still dominant, although generally declining.

BA.2.86.* "Pirola" (38%) began rising steadily from mid-November onwards, led by the JN.1 sub-variant.

#COVID19 #Australia #VIC #Melbourne @auscovid19 #EG_5 #Eris #BA_2_86 #Pirola
🧵

#covid19 #australia #vic #melbourne #eg_5 #eris

Mike Honey @[email protected] · 2023-12-23 · 12:59 UTC

Here's the latest variant picture for New Zealand.

As of mid-December, EG.5.* "Eris" (64%) was still dominant, although starting to decline.

BA.2.86.* "Pirola" (21%) began rising steadily from mid-November onwards, led by the JN.1 sub-variant.

#COVID19 #NZ #EG_5 #Eris #BA_2_86 #Pirola
🧵

#covid19 #nz #eg_5 #eris #ba_2_86 #pirola

Mike Honey @[email protected] · 2023-12-23 · 12:37 UTC

CW: SARS-CoV-2 variants for Australia

Here's the latest variant picture for Australia.

As of mid-December, EG.5.* "Eris" (49%) was about to be overrun by BA.2.86.* "Pirola" (48%), led by the JN.1 sub-variant.

The growth of BA.2.86.* accelerated from late November onwards, in a now-familiar pattern.

#COVID19 #Australia #EG_5 #Eris #BA_2_86 #Pirola @auscovid19
🧵

#covid19 #australia #eg_5 #eris #ba_2_86 #pirola

Mike Honey @[email protected] · 2023-12-19 · 04:39 UTC

CW: SARS-CoV-2 variants for the United States

Here's the latest variant picture for the United States.

As of early December, EG.5.* "Eris" (45%) was still dominant, although starting to decline.

BA.2.86.* "Pirola" (32%) began rising steadily from mid-November onwards.

#COVID19 #USA #BA_2_86 #Pirola #EG_5 #Eris
🧵

#covid19 #usa #ba_2_86 #pirola #eg_5 #eris

Dorothea Zwölfer (sie) @[email protected] · 2023-12-18 · 17:22 UTC

Wirksamkeit der Boosterimpfung gegen #Corona nun nachgewiesen: >>Eine Studie der Klinik für Rheumatologie und Immunologie der Medizinischen Hochschule Hannover (MHH) schließt nun diese Lücke. In Kooperation mit dem MHH-Institut für Immunologie und dem Deutschen Primatenzentrum Göttingen haben die Forschenden die weltweit erste Publikation über den neuen #XBB.1.5 basierten Impfstoff von Biontech veröffentlicht. Im Rahmen der „#COVID-19 Contact (CoCo)“-Studie der MHH wurden 53 MHH-Beschäftigte untersucht, die den #Impfstoff erhalten haben. Anschließend wurde deren Immunreaktion gemessen. Das Ergebnis: Nach der #Impfung mit dem neuen #Booster waren die Antikörper gegen #Omikron #Varianten deutlich angestiegen. Die Arbeit ist in der renommierten Fachzeitschrift „The Lancet Infection Diseases“ veröffentlicht worden. [.. ]
„Wir haben nicht nur eine große Menge neutralisierender Antikörper gegen Omikron XBB.1.5 gefunden, sondern auch gegen andere #Unter-Varianten“, sagt die Oberärztin Professorin Dr. Alexandra Dopfer-Jablonka, die gemeinsam mit ihrem Klinikkollegen Professor Dr. Georg Behrens die Immunstudie leitet. Das bedeutet, der Impfstoff ruft die Immunabwehr nicht nur gegen die aktuell dominierende Corona-Variante XBB.1.5 auf den Plan, sondern aktiviert die körpereigene Abwehr auch gegen die sich gerade ausbreitende Varianten „#Pirola“ (#BA2.86) und „#Eris“ (#EG1.5). „Die #B-Zellen, die Antikörper gegen Omikron produzieren, wurden signifikant mehr und auch die #T-Zellen wurden durch die Impfung gestärkt“, erklärt die Rheumatologin. „Die Daten zeigen, dass die neue #Booster-Impfung ihr Ziel erreicht und darüber hinaus auch Antikörper gegen neue #SARS-CoV-2 Varianten induziert.“ [..] Eine #Auffrischungsimpfung mit dem neuen, angepassten Impfstoff ist laut Ständiger Impfkommission (#Stiko) für alle empfehlenswert, die 60 Jahre oder älter sind. Zudem sollten sich alle Menschen boostern lassen, die wegen einer #Grunderkrankung ein besonderes Risiko für einen schweren Krankheitsverlauf haben. Außerdem empfiehlt die Stiko die Auffrischungsimpfung für Bewohnerinnen und Bewohner von #Pflegeheimen sowie für# Beschäftigte im Pflege- und Gesundheitsbereich. Die Auffrischungsimpfung sollte jährlich wiederholt werden, vorzugsweise im Herbst. << https://idw-online.de/de/news826159